The dendritic cells (DCs) present in lymphoid and non-lymphoid organs are generated from progenitors with myeloid-restricted potential. However, in the thymus a major subset of DCs expressing CD8a and langerin (CD207) appears to stand apart from all other DCs in that it is thought to derive from progenitors with lymphoid potential. Using mice expressing a fluorescent reporter and a diphtheria toxin receptor under the control of the cd207 gene, we demonstrated that CD207 
Introduction
T cells develop in the thymus through discrete stages defined on the basis of the expression of CD4 and CD8 molecules. to the medullary region of the thymus [1] . Following this transition known as positive selection, SP cells expressing TCR with a high affinity for peptide-MHC (pMHC) complexes present on medullary cells are deleted, a process referred to as negative selection. The pool of thymic self-peptides available for TCR selection derives from proteins expressed by thymic epithelial cells (TECs) and by thymic DCs (tDCs). The TECs found in the cortex (cTECs) are primarily devoted to positive selection [2] . In contrast, the medulla is the major site of negative selection due to the ability of medullary TECs (mTECs) to ectopically express selfproteins that are normally found outside the thymus [3] . mTECs are short-lived and upon death can transfer their protein content to the dense network of tDCs present in the medulla [4] [5] [6] . The respective contribution of mTECs and tDCs in central tolerance induction and in the shaping of the T regulatory cell lineage remains to be established [7] . Three subsets of CD11c 1 DCs coexist in mouse thymus [8] . One subset expresses CD45R and corresponds to plasmacytoid DCs (pDCs), whereas the two other tDC subsets are CD45R À and can be distinguished based on the differential expression of CD8a and CD172a (Sirpa). The CD8a low CD172a 1 tDCs arise from quasidifferentiated blood precursors that continuously enter the thymus [9, 10] . In contrast, the CD8a high CD172a À tDCs develop intrathymically and stand apart from all other DCs in that they are reported to originate from early T-cell progenitors (ETPs) [10] [11] [12] . Based on the expression of CD25 and CD44, DN cells can be organized according to the following developmental series: DN1 (CD44
) [13] . DN1 cells can be subdivided further into DN1a, b, c, d and e subsets based on the expression of CD24 and of the c-Kit tyrosine kinase receptor (also called CD117) [13] [14] [15] . DN1a (CD24 ) cells that give rise to the T-cell lineage. DN1a plus DN1b thymocytes are termed ETPs [16, 17] , and it is these ETPs that are thought to generate CD8a high
CD172a
À tDCs in addition to T cells [10] [11] [12] . In contrast, the CD8a 
-tDCs also derive from myeloid precursors [20] , or from precursors that are unrelated to the T-cell lineage and that remain to be characterized [21] .
To further explore the origin of CD8a high CD172a À tDCs and characterize their earliest intrathymic precursors, we took advantage of knockin mice in which an enhanced green fluorescent protein (Langerin-EGFP mice) or a human diphtheria receptor (DTR) fused to an EGFP (Langerin-DTREGFP mice) was placed under the control of the gene coding for langerin (CD207) [22] .
Langerin is a C-type lectin the expression of which was originally described on epidermal Langerhans cells (LC) and later identified on additional DC subsets [23] . Using the highly sensitive Langerin-EGFP reporter mice, we characterized the abundant CD207(EGFP) Analysis of the cells remaining in the heavy-density cell fraction at the end of the enrichment steps showed that their CD25-CD44 profile corresponded to the one expected for DN cells [13] and that the CD11c 1 cells they contained were exclusively found in the DN1 subset ( Fig. 2A) . Consistent with previous work [14] , the analysis of the DN1 cells for CD24 and CD117 expression showed that they comprised DN1c (CD24
) subsets in addition to the DN1a-b subsets (Fig. 2B ). CD11c 1 DN1 cells segregated into DN1c (58.075.6%), DN1d (9.6472.3%) and DN1e (25.175.3%) subsets (Fig. 2B) . Importantly, the DN1c subset was primarily made of CD11c 1 cells and included almost all the CD207(EGFP) 1 cells found in the heavy-density cell fraction ( Fig. 2C and D) . Further characterization of the DN1c cells showed that they markedly differed from the DN1a-b, DN1d and DN1e subsets in that they expressed MHCII molecules and the Fms-like tyrosine kinase receptor 3 (Flt3, also called CD135; Fig. 2C ), a receptor required for the development of most DC subsets and for their maintenance in lymphoid and non-lymphoid tissues [19, 29, 30] . DN1c cells were CCR7 À (data not shown) and expressed low levels of the CX3CR1 chemokine receptor (Fig. 2C ). Consistent with previous data [21] , DN1c cells did not express detectable levels of the IL-7 receptor a chain (CD127) (data not shown). DN1c cells were composed of a minor CD207 À fraction and of a major CD207 1 fraction (Fig. 2C ). When compared with CD11c 
CD8a high tDC precursors
To determine the precursor-product relationship that exists between the distinct populations of CD11c
were found in the heavy-and light-density cell fraction, we followed their kinetics of restoration after injection of DT into Langerin-DTREGFP mice (Fig. 3 ). An almost complete depletion of the CD207 Further analysis of DT-treated Langerin-DTREGFP mice showed that the CD207 1 tDCs found in the light-density cell fraction reappeared with delayed kinetics relative to that of the CD207 1 cells found in the heavy-density cell fraction (Fig. 4A) , an observation consistent with the view that the latter constituted the reservoir of the former. To further support that precursor--product relationship, Langerin-EGFP mice were continuously exposed to 5-bromo-2 0 deoxyuridine (BrdU) for up to 12 days, and the kinetics of BrdU incorporation of the CD207 1 tDCs found in the heavy and light fractions was determined (Fig. 4B ). 'Heavy' and 'light' CD207 1 tDCs had a high turnover resembling that of lymphoid-tissue resident DCs [19] and of migratory DCs prior to their migration to draining LNs [23] . Congruent with the view that the 'light' CD207 1 tDCs were rapidly generated from the 'heavy' CD207 1 tDCs, a one-day delay was observed in the ascending part of the BrdU labeling curve corresponding to the 'light' CD207 1 tDCs as compared with that of the 'heavy' CD207 1 tDCs (Fig. 4B) . Altogether, these data demonstrate the existence of an intrathymic developmental series that starts with bona fide DN1c cells and that proceeds through CD207 [30] due to a mutation in the irf8 gene [33] . Analysis of such mice should reveal whether the Irf8 BXH2/BXH2 mutation also affects the development of the CD207 1 tDCs found in the heavy-density and light-density cell fractions of Langerin-DTREGFP thymi at various time points after the last DT injection. Absolute numbers of cells were determined using Flow count fluorospheres (Coulter) and normalized to the absolute numbers of cells present in thymi of Langerin-DTREGFP mice that received no DT. (B) BrdU was administered continuously for 12 days to a group of two to three B6 mice to compare the BrdU-labeling kinetics of the CD207 1 tDCs found in the light-density and high-density fractions of an Optiprep gradient. Data in (A) are representative of at least three mice per time point and correspond to three independent experiments and data in (B) are representative of three to four independent experiments. Error bars correspond to the SEM. (Fig. 5A) 
CX3-CR1(EGFP)
low cells present in the BM and in peripheral blood of
CX3CR1-EGFP mice for the expression of CD24 and CD117
showed the presence of cells resembling bona fide thymic DN1c (Fig. 6B) . Thymic CD11c
higher levels of MHCII molecules as compared with the pre-DCs found in the BM and the blood (Fig. 6C ), suggesting that they are more mature than pre-DCs. To determine whether canonical DC precursors can give rise to the CD207 1 CD8a high tDCs, MDPs, CDPs and pre-DCs were purified from BM and injected into non-irradiated congenic mice. One week after adoptive transfer, their capacity to differentiate into CD8a high and CD8a low tDCs was measured. Donor-derived DCs were detectable in the thymus of mice injected with MDPs, CDPs and pre-DCs and segregated into both CD8a high and CD8a low subsets (Fig. 7A) . The smaller generative potential of pre-DCs as compared with that of MDPs and CDPs is likely due to their more limited division potential [30] . As expected on the basis of previous studies [36] , MDPs, CDPs and pre-DCs were also BHX2/BXH2 mice were analyzed for the expression of CD24 versus CD117. Gates corresponding to the DN1a-b, DN1c, DN1d and DN1e subsets are as specified in Fig. 2B . Numbers indicate the percentages of cells within the specified gates. (B) tDCs from the light-density cell fraction of wildtype (WT) and irf8 BHX2/BXH2 mice were analyzed for the expression of CD24 versus CD172a. In (A), a cocktail of antibodies directed against CD3e, CD25, CD45R, NK11 and CD11b permitted to exclude cells positive for those markers and to focus on 'lineage negative' (Lin capable of giving rise to the CD8a high and CD8a low DCs found in the spleen (Fig. 7B) . These data together with the fact that mice deprived of Irf8 (Fig. 5 ) or of Batf3 [37] transcription factor lacked both splenic and thymic CD8a 1 DCs highlights their related differentiation program. Therefore, these results formally demonstrate the myeloid origin of the CD8a high tDCs and corroborate our data showing that the earliest signs of intrathymic CD207 expression occurred in DN1c cells and coincided with the expression of markers restricted to the myeloid lineage.
Discussion
The CD8a 1 DCs found in the thymus have been thought to have a lymphoid origin [10] [11] [12] . Considering that CD207 is not expressed outside of the DC lineage [22, 38] and that CD8a high tDCs correspond to CD207 1 tDCs (this study), we used CD207(EGFP) expression to revisit the origin of the CD207 DC subsets. DN1c were found to have limited T lineage potential [14] and their developmental potential remained unclear prior to the present study. In addition, using Langerin-DTREGFP mice, we documented that the developmental series leading to CD207 (Fig. 8) .
To corroborate the myeloid origin of CD207 [21] and with other observations [39, 40] that indirectly suggested a lack of developmental relationship between tDCs and T cells. Consistent with our view that DN1c cells are of myeloid origin and developmentally insulated from the T-cell lineage, conditional ablation of the Notch ligand Delta-like 4 (Dll4) in thymic epithelium affected DN1a-b cells but spared DN1c cells [41] . The previous claim that CD8a high tDCs derive from an intrathymic T-DC bi-potent precursor might stem 1 DN cells that were used in previous studies [11] .
In conclusion, using knockin mice in which an EGFP reporter or a human DTR was placed under the control of the cd207 gene, we have identified the earliest intrathymic precursors of CD207 
CD8a
high tDCs and showed that they correspond to myeloid-type DN1c cells and not to ETPs. These results are consistent with recent fate mapping experiments that showed that tDCs have no lymphoid past [42] . Altogether, those results support the view that myeloid-restricted progenitors generate the whole constellation of DCs present in the body including the thymus.
Materials and methods

Mice
Mice were housed under specific pathogen-free (SPF) conditions and used between 6 and 8 weeks of age. Lang-EGFP and Lang-DTREGFP mice have been described [22] and were backcrossed onto B6 CD45.2 mice for at least ten generations. A single copy of Langerin-DTREGFP is sufficient to render CD207 1 DCs susceptible to DT. Since the Langerin-EGFP allele provides higher levels of EGFP fluorescence than the Langerin-DTREGFP allele, Langerin-EGFP-Langerin-DTREGFP heterozygous mice were used to facilitate depletion monitoring. Hemizygous Cx3cr1 gfp mice [43] were used to allow the expression of CX3CR1 from the wild-type allele. BXH2 C57BL/6J C3H/Hej mice that carry a spontaneous mutation (R924C) in the irf8 gene [33] were purchased from The Jackson Laboratories. All experiments were done in accordance with the French and European guidelines for animal care (DDSV des Bouches-du-Rhône).
In vivo depletion of CD207 1 tDCs
For systemic in vivo depletion of CD207 1 tDCs, mice were injected twice and 15 h apart with 1 mg diphtheria toxin (DT) (Calbiochem). Mice were analyzed for the reappearance of CD207 1 tDCs at different time points after the last DT injection.
Cell preparation
DCs were isolated from lymphoid organs as previously described [44] . Briefly, organs were first cut into small pieces and incubated for 20 min in RPMI-1640 medium with 2% fetal calf serum containing 1 mg/mL of type II collagenase (Worthington Biochemical) and 0.15 mg/mL of DNAse I (Sigma-Aldrich). The resulting cell suspension was treated with 5 mM EDTA for 5 min at room temperature to disrupt DC-T-cell conjugates and lightdensity cells that include DCs were enriched by isopycnic centrifugation on an Optiprep solution (d 5 1.32 g/mL, Abcys). The pellet of high-density cells that forms after Optiprep gradient centrifugation contains immature tDCs among other cells [28] . To enrich for immature tDCs, the pellet was incubated for 20 min at room temperature with rat IgM directed against mouse CD4 (clone RL172.4), followed by the addition of a 1:10 dilution of Low-Tox rabbit complement (Cedarlane Laboratories). After a 30-min incubation at 371C with frequent gentle agitation, viable cells were recovered through centrifugation on a Ficoll gradient (d 5 1.077 g/mL, Pharmacia). As previously demonstrated [15] , the IgM anti-CD4 antibody used in our study does not deplete CD4 low DN1 and DN2 cells.
MACS purification
Beads coated with anti-CD11c antibody (Milteny Biotec) were used to isolate CD11c-expressing cells from bone-marrow, blood and collagenase-DNAse I treated thymus. A sensitive mode of separation (Posselds) was used on the autoMACSPro separator to ensure a high yield of both CD11c int and CD11c hi DCs. To purify CD11c-expressing cells from peripheral blood, blood samples 
CD207
1 CD8a À and CD11c 
CD8a
high stage that is found in the light-density cell fraction (do1.32 g/mL) of an Optiprep gradient. The developmental block observed in mice expressing a mutation in the interferonregulatory factor 8 (irf8) gene is shown. Our findings do not formally rule out the possibility that, under some experimental conditions, early T-cell precursors can give rise to CD207 1
high tDCs. As recently stressed [42] , it is important to distinguish physiological fate choices -as documented in the present study -from cell fates that are possible experimentally.
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were collected from adult mice by direct heart puncture. Erythrocytes were lysed with a NH 4 Cl solution prior to incubation with beads coated with anti-CD11c antibody.
Flow cytometry
Pacific blue-conjugated anti-CD8a (53-6.7, BD Biosciences), antiCD11b (M1/70, BD Biosciences) and anti-CD24 (M1/69, eBioscience); fluorescein isothiocyanate-conjugated anti-CD172a (P84, BD Biosciences); peridinin-chlorophyll-protein complex indodicarbocyanine (Cy5.5)-conjugated anti-CD11b (M1/70, BD Biosciences); phycoerythrin-conjugated anti-CD4 (RM4-5, BD Biosciences), anti-CD117 (2B8, BD Biosciences) and anti-CD172a (P84, BD Biosciences); phycoerythrin-indodicarbocyanine (Cy5)-conjugated anti-CD24 (M1/69, eBioscience), anti-Sca-1 (D7, eBioscience); phycoerythrin-indodicarbocyanine (Cy5.5)-conjugated anti-CD11c (N418, eBioscience); phycoerythrin-indotricarbocyanine (Cy7)-conjugated anti-CD8a (53-6.7, BD Biosciences), anti-CD11c (N418, eBioscience), anti-CD44 (IM7, eBioscience); allophycocyanin-conjugated anti-CD117 (2B8, BD Biosciences); Alexa-700 anti-MHC II (M5/114, eBioscience); allophycocyanin-H7-conjugated anti-CD25 (PC64, BD Biosciences), anti-CD45R (RA3-6B2, BD Biosciences) and anti-CD161c (PK136, BD Biosciences); biotin-conjugated anti-CD135 (A2F10, eBioscience), anti-CD45.1 (A20, BD Biosciences) and anti-CD45.2 (104, eBioscience). Biotin-conjugated antibodies were detected using streptavidin conjugated with Quantum-Dot605 (Invitrogen). Unless stated, a lineage cocktail ('Lin') consisting of APC-Cy7-conjugated anti-CD25, anti-CD45R and anti-CD161c was systematically used in all staining mixes to exclude CD117 1 DN2 cells, pDCs and NK cells, respectively. Detection of intracellular langerin (CD207) was performed on permeabilized cells using a BD Cytofix/Cytoperm kit (BD Biosciences). Langerin was detected with an Alexa647-conjugated anti-CD207 antibody (929F3, Dendritics). Before staining, cells were pre-incubated 10 min on ice with the 2.4G2 antibody to block Fc receptors. In all experiment, Sytox Blue (Invitrogen) was used to exclude dead cells from the analysis. Multiparameter FACS acquisition was performed on a LSRII SORP system (BD Biosciences). Analysis was performed using FACSDiva 6.3 (BD Biosciences) and FlowJo7 (Tree Star) software. Doublets were systematically excluded based on side scatter (SSC) and forward scatter (FSC) parameters.
BrdU incorporation
Mice were injected intraperitoneally (i.p.) with 1.5 mg BrdU (Sigma-Aldrich) to ensure its immediate availability, and their drinking water was supplemented for the indicated time with 0.8 mg/mL of BrdU and 2% glucose and changed daily. Twelve days after continuous BrdU labeling, some mice received BrdUfree drinking water for an additional 2-3 weeks. The amount of BrdU incorporation was determined using the BrdU labeling Flow kit (BD Biosciences).
Adoptive transfer of DC precursors
For adoptive transfer experiment, MDPs, CDPs and pre-DCs were isolated as described [30] . Purified precursor cells (from 1 Â 10 5 to 4 Â 10 5 ) were injected intravenously and their contribution to splenic and tDCs was analyzed a week after adoptive transfer.
Statistical analysis
All results are expressed as the mean7SEM. Statistical tests were performed using a two-tailed Student's t-test.
